Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04384484
Title Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (LOTIS 5)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors ADC Therapeutics S.A.

diffuse large B-cell lymphoma

B-cell lymphoma


Loncastuximab tesirine-lpyl + Rituximab

Gemcitabine + Oxaliplatin + Rituximab

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | CAN | BEL

No variant requirements are available.